Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Pharming Group

Tracked across 3 events · 18 articles · First seen Apr 07, 2026 · Last active Sep 14, 2026

Sentiment
-5
Attention
2
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 10
Business
Impact: Pharming Group will participate in investor conferences to present its business and engage with investors, potentially increasing its visibility and investor interest.
Apr 07, 2026 · 6 articles
2 -60
Regulatory
Impact: Pharming Group is the subject of the investigation and experienced a 22% stock drop after reporting weak Q2 results and cutting guidance. The company faces potential securities litigation and reputational damage, with its legacy product RUCONEST under competitive pressure.
Jul 31, 2026 · 6 articles
2 35
Regulatory
The U.S. United States — Food and Drug Administration approved Joenja (leniolisib), developed by Pharming Group, for children aged 4 to 11 years weighing at least 27 kg with activated phosphoinositide 3-kinase delta syndrome (APDS),…
Impact: Pharming Group is the developer of Joenja and the central beneficiary of the FDA label expansion, which broadens its U.S. market to children aged 4 to 11 and follows a prior regulatory setback. The approval supports revenue growth and reduces regulatory risk, though a further lower-dose application remains pending.
Sep 11, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Pharming Group live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.